omeprazole has been researched along with Adenomatosis, Familial Endocrine in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Evolution of gastrinoma tumoral mass, fasting serum gastrin concentrations, and gastric endocrine cells has been analyzed in 21 patients with the Zollinger-Ellison syndrome committed to long-term omeprazole treatment (up to 7." | 7.68 | Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. ( Bonfils, S; Cadiot, G; Lehy, T; Mignon, M; Ruszniewski, P, 1993) |
"Evolution of gastrinoma tumoral mass, fasting serum gastrin concentrations, and gastric endocrine cells has been analyzed in 21 patients with the Zollinger-Ellison syndrome committed to long-term omeprazole treatment (up to 7." | 3.68 | Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. ( Bonfils, S; Cadiot, G; Lehy, T; Mignon, M; Ruszniewski, P, 1993) |
"argyrophilic gastric carcinoids." | 2.38 | Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. ( Rindi, G; Silini, E; Solcia, E; Villani, L, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jensen, RT | 1 |
Fraker, DL | 1 |
Solcia, E | 1 |
Rindi, G | 1 |
Silini, E | 1 |
Villani, L | 1 |
Maton, PN | 1 |
Cadiot, G | 1 |
Lehy, T | 1 |
Ruszniewski, P | 1 |
Bonfils, S | 1 |
Mignon, M | 1 |
Bardram, L | 1 |
Stadil, F | 1 |
2 reviews available for omeprazole and Adenomatosis, Familial Endocrine
Article | Year |
---|---|
Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Topics: Animals; Carcinoid Tumor; Enterochromaffin Cells; Gastric Acid; Gastric Mucosa; Gastrins; Gastritis; | 1993 |
Review article: the management of Zollinger-Ellison syndrome.
Topics: Diagnosis, Differential; Gastric Acid; Gastrinoma; Gastrins; Histamine H2 Antagonists; Humans; Hydro | 1993 |
3 other studies available for omeprazole and Adenomatosis, Familial Endocrine
Article | Year |
---|---|
Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Blood Chemical Analysis; Combined Modali | 1994 |
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.
Topics: Adult; Aged; APUD Cells; Chi-Square Distribution; Chronic Disease; Female; Gastrinoma; Gastrins; Hum | 1993 |
Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Female; Gastric Acid; Gastrins; Humans; Long-Term Care; Male; Middle Aged; | 1989 |